European public assessment reports

  • Email
  • Help

This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).

The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

Use this search to find information including a public-friendly summary in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.

As of October 2016, EMA publishes the clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure, allowing the public to better understand the Agency’s decision-making. For more information see clinical data publication.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.

More information is available on the Central authorisation procedure and in EPARs: background and context.

Document status

Include:

Browse by letter

Browse by letter for medicines that have a European Public Assessment Report:

Or for other types of content pick from the navigation on the left.

Search by keyword

Search for keyword:

Search by therapeutic area

Browse the database based on therapeutic area:

/

Browse by type

Browse by type:

Download results to spreadsheet
EPAR Search results
Name Active substance Therapeutic area Date of authorisation / refusal Additional monitoring Orphan     Has current safety alert Status
Prandin

repaglinide

Diabetes Mellitus, Type 2 2001-01-29           Authorised
Lumark

lutetium, isotope of mass 177

Radionuclide Imaging 2015-06-19           Authorised
Luminity

perflutren

Echocardiography 2006-09-20           Authorised
Osseor

strontium ranelate

Osteoporosis, Postmenopausal 2004-09-21           Authorised
Natpar

parathyroid hormone

Hypoparathyroidism 2017-04-24           Authorised
Perjeta

pertuzumab

Breast Neoplasms 2013-03-04           Authorised
Strimvelis

autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells

Severe Combined Immunodeficiency 2016-05-26           Authorised
Mycophenolate mofetil Teva

mycophenolate mofetil

Graft Rejection 2008-02-21           Authorised
Leflunomide ratiopharm

leflunomide

Arthritis, Rheumatoid 2010-11-29           Authorised
Efavirenz Teva

efavirenz

HIV Infections 2012-01-09           Authorised
Memantine LEK

memantine hydrochloride

Alzheimer Disease 2013-04-22           Authorised
Tasmar

tolcapone

Parkinson Disease 1997-08-27           Authorised
Gliolan

5-aminolevulinic acid hydrochloride

Glioma 2007-09-07           Authorised
Elocta

efmoroctocog alfa

Hemophilia A 2015-11-19           Authorised
Temozolomide Teva

temozolomide

Glioblastoma Glioma 2010-01-28           Authorised
Yervoy

ipilimumab

Melanoma 2011-07-13           Authorised
DaTSCAN

ioflupane (123l)

Alzheimer Disease Lewy Body Disease Parkinson Disease Tomography, Emission-Computed, Single-Photon 2000-07-27           Authorised
Brineura

cerliponase alfa

Neuronal Ceroid-Lipofuscinoses 2017-05-30           Authorised
Jentadueto

linagliptin / metformin

Diabetes Mellitus, Type 2 2012-07-20           Authorised
Temomedac

temozolomide

Glioblastoma Glioma 2010-01-25           Authorised
Visudyne

verteporfin

Macular Degeneration Myopia, Degenerative 2000-07-27           Authorised
Entacapone Teva

entacapone

Parkinson Disease 2011-02-18           Authorised
Kivexa

abacavir / lamivudine

HIV Infections 2004-12-17           Authorised
Optison

perflutren

Echocardiography 1998-05-18           Authorised
Yttriga

yttrium [90Y] chloride

Radionuclide Imaging 2006-01-19           Authorised